Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells.

Hsu M, Rayasam A, Kijak JA, Choi YH, Harding JS, Marcus SA, Karpus WJ, Sandor M, Fabry Z.

Nat Commun. 2019 Jan 16;10(1):229. doi: 10.1038/s41467-018-08163-0.

2.

Improving flow cytometric methodology for blood cell functional analysis.

Karpus WJ.

Cytometry A. 2015 Jan;87(1):21-2. doi: 10.1002/cyto.a.22604. No abstract available.

3.

Inflammatory macrophage migration in experimental autoimmune encephalomyelitis.

Karpus WJ.

Methods Mol Biol. 2013;1013:161-9. doi: 10.1007/978-1-62703-426-5_10.

PMID:
23625498
4.

TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica.

Sugiura Y, Kamdar K, Khakpour S, Young G, Karpus WJ, DePaolo RW.

Mucosal Immunol. 2013 Nov;6(6):1101-9. doi: 10.1038/mi.2013.5. Epub 2013 Feb 27.

5.

Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene.

Jia Y, Viswakarma N, Crawford SE, Sarkar J, Sambasiva Rao M, Karpus WJ, Kanwar YS, Zhu YJ, Reddy JK.

Mech Dev. 2012 Sep-Dec;129(9-12):193-207. doi: 10.1016/j.mod.2012.08.002. Epub 2012 Sep 7.

6.

Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis.

Reynolds ND, Lukacs NW, Long N, Karpus WJ.

J Immunol. 2011 Sep 1;187(5):2803-13. doi: 10.4049/jimmunol.1100160. Epub 2011 Jul 25.

7.

CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Forde EA, Dogan RN, Karpus WJ.

J Neuroimmunol. 2011 Jul;236(1-2):17-26. doi: 10.1016/j.jneuroim.2011.04.008. Epub 2011 May 14.

8.

CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.

Dogan RN, Long N, Forde E, Dennis K, Kohm AP, Miller SD, Karpus WJ.

J Leukoc Biol. 2011 Jan;89(1):93-104. doi: 10.1189/jlb.0810442. Epub 2010 Oct 12.

9.

IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction.

Shahrara S, Pickens SR, Mandelin AM 2nd, Karpus WJ, Huang Q, Kolls JK, Pope RM.

J Immunol. 2010 Apr 15;184(8):4479-87. doi: 10.4049/jimmunol.0901942. Epub 2010 Mar 12.

10.

Experimental autoimmune encephalomyelitis in the mouse.

Miller SD, Karpus WJ, Davidson TS.

Curr Protoc Immunol. 2010 Feb;Chapter 15:Unit 15.1. doi: 10.1002/0471142735.im1501s88.

PMID:
20143314
11.

Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.

Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M, Dennis MK, Prossnitz ER, Karpus WJ, Horuk R.

J Neuroimmunol. 2009 Sep 29;214(1-2):67-77. doi: 10.1016/j.jneuroim.2009.06.023. Epub 2009 Aug 6.

12.

Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis.

Elhofy A, Depaolo RW, Lira SA, Lukacs NW, Karpus WJ.

J Neuroimmunol. 2009 Aug 18;213(1-2):91-9. doi: 10.1016/j.jneuroim.2009.05.011. Epub 2009 Jun 17.

13.

MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult.

Thompson WL, Karpus WJ, Van Eldik LJ.

J Neuroinflammation. 2008 Aug 15;5:35. doi: 10.1186/1742-2094-5-35.

14.

Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.

Karpus WJ, Reynolds N, Behanna HA, Van Eldik LJ, Watterson DM.

J Neuroimmunol. 2008 Oct 15;203(1):73-8. doi: 10.1016/j.jneuroim.2008.06.039.

16.

Experimental autoimmune encephalomyelitis in the mouse.

Miller SD, Karpus WJ.

Curr Protoc Immunol. 2007 May;Chapter 15:Unit 15.1. doi: 10.1002/0471142735.im1501s77.

17.
18.

CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Bennett JL, Elhofy A, Charo I, Miller SD, Dal Canto MC, Karpus WJ.

Viral Immunol. 2007 Spring;20(1):19-33.

PMID:
17425418
19.

Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Karpus WJ, Kennedy KJ, Fife BT, Bennett JL, Dal Canto MC, Kunkel SL, Lukacs NW.

J Neurovirol. 2006 Aug;12(4):251-61.

20.

The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection.

Depaolo RW, Lathan R, Rollins BJ, Karpus WJ.

Infect Immun. 2005 Oct;73(10):6514-22.

21.

Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis.

Elhofy A, Wang J, Tani M, Fife BT, Kennedy KJ, Bennett J, Huang D, Ransohoff RM, Karpus WJ.

J Leukoc Biol. 2005 Feb;77(2):229-37. Epub 2004 Nov 11.

PMID:
15539456
22.

Differential activation of astrocytes by innate and adaptive immune stimuli.

Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD.

Glia. 2005 Feb;49(3):360-74.

PMID:
15538753
23.

CCR5 regulates high dose oral tolerance by modulating CC chemokine ligand 2 levels in the GALT.

DePaolo RW, Lathan R, Karpus WJ.

J Immunol. 2004 Jul 1;173(1):314-20.

26.

Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).

Monaghan SA, Peterson LC, James C, Marszalek L, Khoong A, Bachta DJ, Karpus WJ, Goolsby CL.

Cytometry B Clin Cytom. 2003 Nov;56(1):30-42.

27.
28.

Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores.

Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Y, Karpus WJ, Luo K, Jovanovic B, Traynor A, Karlin K, Stefoski D, Burns WH.

Blood. 2003 Oct 1;102(7):2373-8. Epub 2003 Jul 3.

29.
30.

Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors.

Elhofy A, Kennedy KJ, Fife BT, Karpus WJ.

Immunol Res. 2002;25(2):167-75. Review.

PMID:
11999170
31.
32.

Keystone Symposia: chemokines and chemokine receptors. 16-21st February 2001, Taos, NM, USA.

Karpus WJ, Fife BT.

Expert Opin Biol Ther. 2001 May;1(3):549-53.

PMID:
11727525
33.

Chemokines and central nervous system disorders.

Karpus WJ.

J Neurovirol. 2001 Dec;7(6):493-500. Review.

PMID:
11704881
34.

Chemokine Regulation of Immune-mediated Demyelinating Disease.

Karpus WJ, Kennedy KJ, Fife BT, Hoffman LM.

ILAR J. 1999 Sep;40(4):183-189.

PMID:
11406697
35.
36.

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.

Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ.

J Exp Med. 2000 Sep 18;192(6):899-905.

37.

Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells.

Matthews E, Yang T, Janulis L, Goodwin S, Kundu SD, Karpus WJ, Lee C.

Br J Cancer. 2000 Aug;83(4):519-25.

38.

Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease.

Hoffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ.

J Neurovirol. 1999 Dec;5(6):635-42.

PMID:
10602404
39.

Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis.

Kennedy KJ, Karpus WJ.

J Clin Immunol. 1999 Sep;19(5):273-9. Review.

PMID:
10535603
40.

Chemokine regulation of inflammatory-mediated nervous system diseases.

Karpus WJ.

J Neurovirol. 1999 Feb;5(1):1-2. No abstract available.

PMID:
10190684
41.

Chemokine regulation of CNS T-cell infiltration in experimental autoimmune encephalomyelitis.

Hoffman LM, Karpus WJ.

Res Immunol. 1998 Nov-Dec;149(9):790-4; discussion 846-7, 855-60. Review. No abstract available.

PMID:
9923634
44.
46.
47.

C-C chemokines differentially alter interleukin-4 production from lymphocytes.

Lukacs NW, Chensue SW, Karpus WJ, Lincoln P, Keefer C, Strieter RM, Kunkel SL.

Am J Pathol. 1997 May;150(5):1861-8.

48.

Differential CC chemokine-induced enhancement of T helper cell cytokine production.

Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA.

J Immunol. 1997 May 1;158(9):4129-36.

PMID:
9126972
49.

Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.

Karpus WJ, Kennedy KJ, Smith WS, Miller SD.

J Neurosci Res. 1996 Aug 15;45(4):410-23.

PMID:
8872901

Supplemental Content

Loading ...
Support Center